Literature DB >> 15227186

Coronary angioplasty in emergency treatment of myocardial infarction in a community-hospital setting.

R P Sotolongo1, M L Smith, W S Margolis.   

Abstract

From July 1986 through June 1988, 135 consecutive patients with myocardial infarction, including 23 in cardiogenic shock, were treated with percutaneous transluminal coronary angioplasty in a community-hospital setting. In 109 (81%) of the cases, angioplasty was successful, resulting in brisk anterograde flow and in residual stenosis of less than 50%. The success rate was 88% (99/112) for patients not in cardiogenic shock and 43% (10/23) for those in shock. During the term of hospitalization, clinically evident total reocclusion occurred in 5 (4%) patients not in shock on presentation (2 of these experienced anterior infarction, and 3 inferior infarction); repeat angioplasty was performed successfully in all 5. No clinical reocclusion was detected in the smaller group of patients admitted in shock. Eleven patients (8%) underwent emergency coronary artery bypass grafting following the coronary angioplasty procedure: 4 for failed angioplasty in the infarct-related artery, and the other 7 for severe triple-vessel disease. Hospital mortality was 0.9% (1/112) for patients not in cardiogenic shock and 52% (12/23) for those admitted in shock, for an overall rate of 10% (13/135). Among patients whose balloon angioplasty was successful, hospital mortality was 0% for those not in shock and 30% (3/10) for those in shock. Among patients whose angioplasty failed, however, mortality was 8% (1/13) for those not in shock and 69% (9/13) for those admitted in shock.

Entities:  

Year:  1990        PMID: 15227186      PMCID: PMC324897     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  22 in total

1.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.

Authors:  H K Gold; R C Leinbach; H D Garabedian; T Yasuda; J A Johns; E B Grossbard; I Palacios; D Collen
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

2.  Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial.

Authors:  S Scheidt; G Wilner; H Mueller; D Summers; M Lesch; G Wolff; J Krakauer; M Rubenfire; P Fleming; G Noon; N Oldham; T Killip; A Kantrowitz
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

3.  Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.

Authors:  P W Serruys; W Wijns; M van den Brand; V Ribeiro; P Fioretti; M L Simoons; C J Kooijman; J H Reiber; P G Hugenholtz
Journal:  Br Heart J       Date:  1983-09

4.  High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.

Authors:  L D Hillis; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; G Knatterud; P Ludbrook
Journal:  J Am Coll Cardiol       Date:  1985-11       Impact factor: 24.094

5.  Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.

Authors:  D G Harrison; D W Ferguson; S M Collins; D J Skorton; E E Ericksen; J M Kioschos; M L Marcus; C W White
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

6.  Treatment of myocardial infarction in a community hospital coronary care unit. Experience with 1,246 patients.

Authors:  M Mirowski; W Israel; A G Antonopoulos; M M Mower; A I Mendeloff
Journal:  Arch Intern Med       Date:  1978-02

7.  Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction.

Authors:  G O Hartzler; B D Rutherford; D R McConahay; W L Johnson; B D McCallister; G M Gura; R C Conn; J E Crockett
Journal:  Am Heart J       Date:  1983-11       Impact factor: 4.749

8.  Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction.

Authors:  S E Papapietro; W A MacLean; A W Stanley; R G Hess; N Corley; J G Arciniegas; T B Cooper
Journal:  Am J Cardiol       Date:  1985-01-01       Impact factor: 2.778

9.  Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography.

Authors:  J W Kennedy; G G Gensini; G C Timmis; C Maynard
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

10.  Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction.

Authors:  J Meyer; W Merx; H Schmitz; R Erbel; T Kiesslich; R Dörr; H Lambertz; C Bethge; W Krebs; P Bardos; C Minale; B J Messmer; S Effert
Journal:  Circulation       Date:  1982-11       Impact factor: 29.690

View more
  1 in total

Review 1.  Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.

Authors:  Thomas L Lynch; Sakthivel Sadayappan
Journal:  Proteomics Clin Appl       Date:  2014-07-14       Impact factor: 3.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.